Mindray Announces Third Quarter 2009 Financi...(period in 2008. -- Net revenues gener...),Health

First nine months of 2009 EBITDA increased 36.0% year-over-year to $142.3 million from $104.6 million in the first nine months of 2008.

First nine months of 2009 net income increased 32.0% year-over-year to $101.8 million from $77.1 million in the first nine months of 2008. First nine months of 2009 non-GAAP net income increased 9.3% year-over-year to $105.7 million from $96.7 million in the first nine months of 2008.

First nine months of 2009 diluted earnings per share increased 33.7% year-over-year to $0.90 from $0.68 in the first nine months of 2008. First nine months of 2009 non-GAAP diluted earnings per share increased 10.7% to $0.94 from $0.85 in the first nine months of 2008.

    Business Outlook for Full Year 2009
    Mindray updates its current outlook for the full year 2009, which includes:
    -- 2009 net revenue to grow at a rate of 10% to 13% year-over-year.
    -- Non-GAAP EPS to grow slightly more than 10% over 2008.
    -- Capital expenditure to remain in the range of $50 million to $60
       million.
    -- Share based compensation to be approximately $12 million, based on
       issuances to date, which does not take into account any additional
       share grant that may come later this year, if any.
    -- Amortization of intangible assets to be $10 million including April
       2006 acquisition of minority interest and May 2008 acquisition of
       Datascope patient monitoring business.

The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.

"The updated guidance conveys our confidence in delivering solid operational and financial res
'/>"/>